Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: The MASTER Study (MAmmary Cancer STatin ER Positive Study) [Phase 3]
Phase 3 clinical trial update for the MASTER Study investigating mammary cancer statin ER-positive disease; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer [Phase 3]
Phase 3 trial comparing trastuzumab emtansine plus pertuzumab versus trastuzumab plus pertuzumab and a taxane as adjuvant therapy in operabl…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating Niraparib as neoadjuvant therapy for breast cancer showed antitumor activity and assessed safety; results …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial assessing concurrent adjuvant carboplatin with accelerated radiotherapy in triple negative breast cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer [Phase 2, Phase 3]
A clinical trial update assessing the efficacy of adding statins to neoadjuvant chemotherapy for breast cancer (Phase 2/3).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: A Confirmation Study of Eribulin in Combination With Capecitabine [Phase 1, Phase 2]
A phase 1/2 study evaluating eribulin in combination with capecitabine in metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: What Matters Most: Choosing the Right Breast Cancer Surgery for You [NA]
Clinical trial update on choosing the right breast cancer surgery; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake [Phase 1, Phase 2]
Phase 1/2 trial update evaluating genetic risk estimation for breast cancer prior to preventive medication uptake.
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients [Phase 3]
Phase 3 trial comparing Leucostim to Neupogen in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer [NA]
A clinical trial studying preoperative SABR for early-stage breast cancer has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer [Phase 2]
Phase 2 study evaluating palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive, HER2-negative invasive br…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating inetetamab with pyrotinib and chemotherapy for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib in combination with fulvestrant for HER2-positive, HR-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating TKI258 (pacritinib? or unknown) in FGFR1 amplified and non-amplified metastatic HER2-negative breast cancer …
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients [Phase 1, Phase 2]
Phase I-II trial to find the maximum tolerated dose of AUY922 in advanced solid malignancies and assess efficacy in HER2+ or ER+ locally adv…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer [Phase 1, Phase 2]
Phase I/II trial update for BGT226 in adults with advanced solid malignancies including breast cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086) [Phase 2]
Phase 2 trial update for pembrolizumab monotherapy in metastatic triple-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy. [Phase 4]
A Phase 4 clinical trial evaluating the effects of a herbal combination (Bromelain, Boswellia Serrata Casperome, Centella Asiatica, and vita…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Vitamin D Supplementation in Women With DCIS and/or LCIS [EARLY_Phase 1]
Early-phase trial evaluating vitamin D supplementation in women with ductal carcinoma in situ or lobular carcinoma in situ; study terminated…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer [Phase 3]
A Phase 3 neoadjuvant study evaluating Navelbine in HER2-positive breast cancer is ongoing; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer [Phase 2]
Phase 2 trial investigating 99mTc-rhAnnexin V-128 imaging for cardiotoxicity in early breast cancer patients treated with doxorubicin; study…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer [Phase 2]
Phase 2 trial results for GTx-024 in ER+/AR+ breast cancer have been completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients [Phase 2]
Phase 2 trial update on neoadjuvant chemo-endocrine therapy plus immunotherapy for pre-menopausal luminal B breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer [Phase 2]
A Phase 2 clinical trial update evaluating nab-paclitaxel in combination with pyrotinib as postoperative adjuvant therapy for HER2-positive …
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab [Phase 1, Phase 2]
A Phase 1/2 study evaluating AUY922 in combination with trastuzumab in patients with advanced HER2-positive breast cancer previously treated…